SAMSONITE (01910) released its interim results, reporting a profit attributable to shareholders of 90.9 million USD, a decrease of 23.1% year-on-year.
Samsonite (01910) announced its interim results for 2026, with the group achieving net sales of 1.6806 billion USD, an increase of 1.1% year-on-year; profit attributable to equity holders was 90.9 million USD, a decrease of 23.1% year-on-year; and basic earnings per share were 0.066 USD.
SAMSONITE (01910) announced its mid-year results for 2026, reporting a net sales of $1.6806 billion, an increase of 1.1% year-on-year; the profit attributable to equity holders was $90.9 million, a decrease of 23.1%; and the basic earnings per share were $0.066.
For the six months ending June 30, 2026, the company's net sales were $1.6806 billion, an increase of $18.9 million or 1.1% compared to $1.6617 billion for the six months ended June 30, 2025. On a constant currency basis, net sales decreased by 0.7%. The annual weakness of the US dollar positively impacted the year-on-year improvement in reported net sales. The increase in reported net sales was also driven by growth in the company's DTC channels, the SAMSONITE brand, and the lifestyle bag category.
During the period, net sales were adversely affected by ongoing conflicts in Iran and other parts of the Middle East. These conflicts triggered inflationary pressures, leading to weak travel demand and diminished consumer confidence, especially in North America. Excluding the sales from the Middle East and Indian markets, which were most severely impacted by the conflicts, the consolidated net sales for the six months ending June 30, 2026, increased by 3.1% year-on-year (an increase of 0.7% on a constant currency basis).
Related Articles

The 2026 Asia Pacific Pharmacy Conference will focus on the transformation of pharmacies: a restructuring from selling medicine to health service stations.

SUNSHINE OIL (02012): Doug Brown P. Eng resigns as Chief Executive Officer

Metallurgical Corporation of China (01618): Li Zhongze has been appointed as executive director.
The 2026 Asia Pacific Pharmacy Conference will focus on the transformation of pharmacies: a restructuring from selling medicine to health service stations.

SUNSHINE OIL (02012): Doug Brown P. Eng resigns as Chief Executive Officer

Metallurgical Corporation of China (01618): Li Zhongze has been appointed as executive director.

RECOMMEND





